• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Miscibility of semisynthetic human ultralente insulin with short-acting insulin in insulin-dependent diabetic patients.

作者信息

Lunetta M, di Mauro M, Crimi S, Sudano L, Mughini L

机构信息

II Istituto di Patologia Medica e Malattie del Ricambio dell'Università, Catania, Italy.

出版信息

Acta Diabetol Lat. 1988 Jul-Sep;25(3):263-9. doi: 10.1007/BF02624822.

DOI:10.1007/BF02624822
PMID:3071068
Abstract

In 15 insulin dependent diabetics (IDDM), treated with human monocomponent insulin, the absorption of Actrapid HM mixed with Ultratard HM was evaluated. Thirty U of Ultratard HM and 10 U of Actrapid HM were injected separately or together immediately after mixing. Free insulin and plasma glucose (PG) were measured four hours after the administration. Free insulin levels were significantly higher after 15 (2p less than 0.01), 60 (2p less than 0.05) and 90 min (2p less than 0.005) when the two insulins were injected separately. PG values were significantly lower (2p less than 0.05) (7.63 +/- 4.06 mmol/l) at 120 min when the two insulins were injected separately compared to the mixture (9.45 +/- 4.22 mmol/l). In conclusion, mixing Ultratard HM and Actrapid HM 3:1, we observed a decrease of early Actrapid absorption and a slower lowering of PG values.

摘要

相似文献

1
Miscibility of semisynthetic human ultralente insulin with short-acting insulin in insulin-dependent diabetic patients.
Acta Diabetol Lat. 1988 Jul-Sep;25(3):263-9. doi: 10.1007/BF02624822.
2
Prevention of early-morning hyperglycemia in IDDM patients with long-acting zinc insulin.
Diabetes Care. 1992 Feb;15(2):173-7. doi: 10.2337/diacare.15.2.173.
3
Improvement in morning hyperglycaemia with basal human ultratard and prandial human actrapid insulin--a comparison of multiple injection regimens.基础人超长效胰岛素和餐时人速秀林胰岛素改善清晨高血糖——多种注射方案的比较
Diabet Med. 1988 Oct;5(7):671-5. doi: 10.1111/j.1464-5491.1988.tb01078.x.
4
NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue.诺和佳基础胰岛素:一种新型可溶性长效胰岛素类似物的药代动力学
BMJ. 1989 Aug 12;299(6696):415-9. doi: 10.1136/bmj.299.6696.415.
5
Reduction in insulin antibodies 42 months after transfer from porcine to human monocomponent insulins.
Diabetes Res. 1988 Sep;9(1):19-20.
6
Miscibility of human semisynthetic regular and lente insulin and human biosynthetic regular and NPH insulin.人半合成正规胰岛素和慢胰岛素以及人生物合成正规胰岛素和中性鱼精蛋白锌胰岛素的混合性
Diabetes Care. 1987 Jul-Aug;10(4):473-7. doi: 10.2337/diacare.10.4.473.
7
Comparison of glycaemic control in diabetic patients treated with morning or evening human ultratard insulin.早晨或晚上注射人超长效胰岛素治疗的糖尿病患者血糖控制情况的比较。
Diabet Med. 1987 Jan-Feb;4(1):53-5. doi: 10.1111/j.1464-5491.1987.tb00829.x.
8
Mixtures of human intermediate and human regular insulin in type 1 diabetic patients. Evaluation of free insulin levels and insulin action on glucose metabolism after combined and separate subcutaneous administration.1型糖尿病患者中人类中效胰岛素与常规胰岛素的混合制剂。联合及单独皮下给药后游离胰岛素水平及胰岛素对葡萄糖代谢作用的评估。
Diabetes Res Clin Pract. 1988 Sep 5;5(3):185-90. doi: 10.1016/s0168-8227(88)80086-x.
9
Effect of storage temperature of insulin on pharmacokinetics and pharmacodynamics of insulin mixtures injected subcutaneously in subjects with type 1 (insulin-dependent) diabetes mellitus.胰岛素储存温度对1型(胰岛素依赖型)糖尿病患者皮下注射胰岛素混合制剂药代动力学和药效学的影响。
Diabetologia. 1988 Nov;31(11):811-5. doi: 10.1007/BF00277482.
10
Different daily blood glucose control and free insulin levels during treatment with mixtures of soluble and lente or soluble and NPH semisynthetic human insulins.
Diabete Metab. 1989 Jul-Aug;15(4):182-7.

本文引用的文献

1
Intermediate-acting insulin preparations: NPH and lente.中效胰岛素制剂:NPH和lente。
Diabetes Care. 1980 Sep-Oct;3(5):623-6. doi: 10.2337/diacare.3.5.623.
2
Factors influencing the absorption, serum insulin concentration, and blood glucose responses after injections of regular insulin and various insulin mixtures.影响注射普通胰岛素及各种胰岛素混合物后吸收、血清胰岛素浓度和血糖反应的因素。
Diabetes Care. 1981 May-Jun;4(3):366-76. doi: 10.2337/diacare.4.3.366.
3
Absorption kinetics of semisynthetic human insulin and biosynthetic (recombinant DNA) human insulin.
半合成人胰岛素和生物合成(重组DNA)人胰岛素的吸收动力学。
Diabetes Care. 1982 Nov-Dec;5 Suppl 2:23-8. doi: 10.2337/diacare.5.2.s23.
4
Absorption kinetics and biologic effects of subcutaneously injected insulin preparations.皮下注射胰岛素制剂的吸收动力学及生物学效应
Diabetes Care. 1982 Mar-Apr;5(2):77-91. doi: 10.2337/diacare.5.2.77.
5
Type I diabetes . . . regimens, targets, and caveats.
Diabetes Care. 1982 Sep-Oct;5(5):547-52.
6
Miscibility of human and bovine ultralente insulin with soluble insulin.人及牛超长效胰岛素与可溶性胰岛素的混溶性
Br Med J (Clin Res Ed). 1984 Dec 15;289(6459):1656-7. doi: 10.1136/bmj.289.6459.1656-a.
7
Human ultralente insulin.人超长效胰岛素。
Br Med J (Clin Res Ed). 1984 Mar 3;288(6418):665-8. doi: 10.1136/bmj.288.6418.665.
8
Absorption kinetics and action profiles of mixtures of short- and intermediate-acting insulins.
Diabetologia. 1984 Dec;27(6):558-62. doi: 10.1007/BF00276967.
9
Miscibility of human lente insulin with soluble insulin.人慢胰岛素与可溶性胰岛素的混溶性。
Diabetologia. 1985 Apr;28(4):252. doi: 10.1007/BF00282244.
10
The effect of mixing human soluble and human crystalline zinc-suspension insulin: plasma insulin and blood glucose profiles after subcutaneous injection.混合人可溶性和人结晶锌混悬胰岛素的效果:皮下注射后的血浆胰岛素和血糖曲线
Diabet Med. 1985 May;2(3):177-80. doi: 10.1111/j.1464-5491.1985.tb00629.x.